Vikas Lifecare Limited (VIKASLIFE) AI Stock Analysis

2 Followers

Vikas Lifecare Limited

(NSE:VIKASLIFE)

Select Model

Rating:50Neutral

Price Target:INR 1.00▼(-18.03% Downside)

Action:reiterated

Date:08/27/26

Moderate score driven mainly by balance sheet stability and recent cash flow gains, tempered by earnings volatility, slowing growth, and weak valuation from ongoing losses.

Positive Factors

Revenue Scale-UpThe substantial multi-year revenue increase indicates that Vikas Lifecare has expanded its commercial scale across polymer and chemical applications. A larger revenue base can improve operating leverage and customer reach, although future benefit depends on restoring sustainable profitability.

Negative Factors

Weak Operating ProfitabilityNegative operating profit and EBITDA show that revenue scale has not yet translated into dependable core earnings. Persistently thin or negative operating margins would limit reinvestment capacity, weaken earnings quality, and make the business more exposed to operating-cost pressure.

Vikas Lifecare Limited (VIKASLIFE) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 2.25B
Dividend Yield: ―
Average Volume (3M): 434.81K
Price to Earnings (P/E): -1.7
Beta (1Y): 1.21
Revenue Growth: 4.03%
EPS Growth: -1217.25%
Country: India
Employees: 36
Sector: General
Sector Strength: 55
Industry: Chemicals - Specialty

Vikas Lifecare Limited Business Overview & Revenue Model

Company Description

Established in 1995 and headquartered in New Delhi, India, Vikas Lifecare Limited (which operated as Vikas Multicorp Limited until its name change in April 2021) is a multifaceted company with diverse operations. Its business is organized into Real E...

Vikas Lifecare Limited Financial Statement Overview

Summary

Mixed results with revenue growth slowing after early surges, inconsistent profitability, and low margins, offset by a stronger balance sheet with reduced leverage and a recent positive cash flow turnaround.

Income Statement

40Negative

Balance Sheet

75Positive

Cash Flow

50Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	4.99B	4.99B	4.80B	4.46B	4.76B	3.01B
Gross Profit	81.40M	55.92M	38.79M	262.04M	243.20M	101.59M
EBITDA	177.46M	195.84M	43.56M	240.93M	-160.56M	427.24M
Net Income	-1.11B	184.09M	-106.14M	140.29M	-152.99M	286.99M
Balance Sheet
Total Assets	7.60B	7.60B	7.29B	5.55B	4.55B	3.21B
Cash, Cash Equivalents and Short-Term Investments	10.80M	10.80M	431.74M	159.36M	113.13M	77.05M
Total Debt	1.05B	1.05B	767.00M	344.90M	304.07M	230.77M
Total Liabilities	2.09B	2.09B	1.96B	762.67M	1.21B	1.21B
Stockholders Equity	5.51B	5.51B	5.32B	4.77B	3.31B	1.99B
Cash Flow
Free Cash Flow	0	4.35B	-2.36B	-577.20M	-1.28B	-281.03M
Operating Cash Flow	0	4.36B	-2.24B	-417.48M	-1.10B	-148.84M
Investing Cash Flow	0	-4.67B	1.03B	-906.01M	-366.38M	-385.14M
Financing Cash Flow	0	261.45M	1.12B	1.37B	1.51B	590.87M

Vikas Lifecare Limited Technical Analysis

Technical Analysis SentimentPositive

Last Price1.22

Price Trends

50DMA1.20Positive

100DMA1.27Negative

200DMA1.39Negative

Market Momentum

MACD-0.00Negative

RSI60.23Neutral

STOCH93.94Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VIKASLIFE, the sentiment is Positive. The current price of 1.22 is above the 20-day moving average (MA) of 1.16, above the 50-day MA of 1.20, and below the 200-day MA of 1.39, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 60.23 is Neutral, neither overbought nor oversold. The STOCH value of 93.94 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:VIKASLIFE.

Vikas Lifecare Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:VIKASLIFE against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:AARTISURF	66Neutral	INR 4.20B	23.82	―	0.19%	25.22%	20.38%
IN:ROSSARI	65Neutral	INR 23.79B	15.59	―	0.12%	19.76%	11.74%
IN:AVTNPL	63Neutral	INR 14.60B	18.06	―	0.80%	41.25%	65.19%
IN:DYNPRO	61Neutral	INR 2.81B	12.54	―	0.66%	9.37%	25.43%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:OAL	50Neutral	INR 16.53B	158.85	―	0.10%	14.33%	5.73%
IN:VIKASLIFE	50Neutral	INR 2.23B	-1.68	―	―	4.03%	-1217.25%

* General Sector Average

Performance Comparison

IN:VIKASLIFE and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:VIKASLIFE	Vikas Lifecare Limited	1.22	-0.77	-38.69%
IN:AARTISURF	Aarti Surfactants Ltd.	520.75	71.92	16.02%
IN:AVTNPL	AVT Natural Products Limited	99.41	27.65	38.52%
IN:DYNPRO	Dynemic Products Limited	227.10	-49.43	-17.88%
IN:OAL	Oriental Aromatics Ltd.	488.10	142.30	41.15%
IN:ROSSARI	Rossari Biotech Ltd	429.05	-200.79	-31.88%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 27, 2026

Vikas Lifecare Limited AI Stock Analysis